authentication.decisionresourcesgroup.com

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
Acute Coronary Syndrome - Epidemiology - Emerging Markets | Clarivate
https://clarivate.com/life-sciences-healthcare/report/epidcv0031-biopharma-acute-coronary-syndrome-epidemiology-emerging-markets
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-geography=germany&wpv_paged=2&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Market Access Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/market-access?clv-marketaccess-product=health-plan-data-analysis&wpv_paged=3&wpv_view_count=297634
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Renal Cell Carcinoma - Landscape & Forecast - Disease Landscape & Forecast (G...
https://clarivate.com/life-sciences-healthcare/report/dlsfon0009-2026-biopharma-renal-cell-carcinoma-landscape-forecast-disease-landscape-forecast-g7
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Darts-IP APIs - Access To Global Litigation Data | Clarivate
http://timbeckett-writing.com/index-131.html
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Taking the Pulse - US - 2015 - Digital HCP Sources - Segmentation - All Physi...
https://clarivate.com/life-sciences-healthcare/report/ssmxu13815-digital-taking-the-pulse-us-2015-digital-hcp-sources-segmentation-all-physicians-treating-hiv-no
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Trust Center | Clarivate
https://clarivate.com/trust-center
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Crohn's Disease | Treatment Algorithms: Claims Data Analysis | Pediatric | US...
https://clarivate.com/life-sciences-healthcare/report/algoim0044-2025-biopharma-crohns-disease-treatment-algorithms-claims-data-analysis-pediatric-us-2025
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Venous Thromboembolism - Epidemiology - Extrapolated Worldwide Coverage | Cla...
https://clarivate.com/life-sciences-healthcare/report/epidcv0067-biopharma-venous-thromboembolism-epidemiology-extrapolated-worldwide-coverage
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Idiopathic Pulmonary Fibrosis - Unmet Need - Unmet Need - Idiopathic Pulmonar...
https://clarivate.com/life-sciences-healthcare/report/unneim0025-2024-biopharma-idiopathic-pulmonary-fibrosis-unmet-need-unmet-need-idiopathic-pulmonary-fibrosis-us-eu
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
마켓 액세스 인사이트 리포트 | 클래리베이트
https://clarivate.com/life-sciences-healthcare/ko/research-reports/market-access?wpv_paged=5&wpv_view_count=297634
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Wet Age-related Macular Degeneration - Epidemiology - Epidemiology - Wet Age-...
https://clarivate.com/life-sciences-healthcare/report/epidop0004-biopharma-wet-age-related-macular-degeneration-epidemiology-epidemiology-wet-age-related-macular-4
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
IP Patent & Trademark Management Software | Clarivate
http://timbeckett-writing.com/index-78.html
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Bladder Cancer and Upper Tract Urothelial Carcinoma - Geographic Focus: China...
https://clarivate.com/life-sciences-healthcare/report/concon0011-2026-biopharma-bladder-cancer-and-upper-tract-urothelial-carcinoma-geographic-focus-china-bladder-cancer-and
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Clarivate | Clarivate
https://clarivate.com/zh
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Clarivate | Clarivate
https://clarivate.com/zh
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Systemic Lupus Erythematosus | Disease Landscape & Forecast | G7 | 2025 | Cla...
https://clarivate.com/life-sciences-healthcare/report/dlsfim0008-2025-biopharma-systemic-lupus-erythematosus-disease-landscape-forecast-g7-2025
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?wpv_paged=5&wpv_post_search=special topics&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Biopharma Portfolio Strategy and Business Development
http://timbeckett-writing.com/index-41.html
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Prostate Cancer - Epidemiology - Mature Markets Data | Clarivate
https://clarivate.com/life-sciences-healthcare/report/epidon0038-biopharma-prostate-cancer-epidemiology-mature-markets-data
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
USPTO | Clarivate
https://clarivate.com/intellectual-property/blog/tag/uspto?clv_tag=uspto
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Patent Prosecution Services & Preparation Support | Clarivate
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Cortellis Product Intelligence training resources | Clarivate
https://clarivate.com/life-sciences-healthcare/training-support/product-intelligence
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Cigna Group | Massachusetts | 2025 | Health Plan Profile | Clarivate
https://clarivate.com/life-sciences-healthcare/report/hpppma1009-marketaccess-cigna-group-massachusetts-2025-health-plan-profile
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Have the 2010s been good for peer review? | Clarivate
https://clarivate.com/academia-government/blog/have-the-2010s-been-good-for-peer-review
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Jonathan Collins | Clarivate
http://timbeckett-writing.com/index-983.html
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Medtech Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/medtech-insights?clv-medtech-therapy-area=transcatheter-embolization-and-occlusion-devices&wpv_paged=5&wpv_view_count=297644
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Dialog Solutions for Medical Literature Review | Clarivate
https://clarivate.com/life-sciences-healthcare/research-development/pharmacovigilance-drug-safety/dialog?lid=dialog
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
思想领导力 - Life Sciences & Healthcare
https://www.clarivate.com.cn/life-sciences-healthcare/reports
clarivate.com.cn
13 8 25
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-therapy-areas=neuropathic-pain&wpv_paged=3&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Medtech Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/medtech-insights?lid=d&wpv_paged=164&wpv_view_count=297644
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Crohn's Disease | Treatment Algorithms: Claims Data Analysis | Pediatric | US...
https://clarivate.com/life-sciences-healthcare/report/algoim0044-2024-biopharma-crohns-disease-treatment-algorithms-claims-data-analysis-pediatric-us-2024
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Obesity Interventions - Market Insights - Middle East | Clarivate
https://clarivate.com/life-sciences-healthcare/report/m360oo0012-medtech-obesity-interventions-market-insights-middle-east
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-therapy-areas=human-immunodeficiency-virus&wpv_paged=2&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-therapy-areas=crohns-disease&wpv_paged=2&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Multiple Sclerosis - Landscape & Forecast - Disease Landscape & Forecast (G7)...
https://clarivate.com/life-sciences-healthcare/report/dlsfcg0004-2026-biopharma-multiple-sclerosis-landscape-forecast-disease-landscape-forecast-g7
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Crohn's Disease - Current Treatment - Current Treatment: Physician Insights –...
https://clarivate.com/life-sciences-healthcare/report/cutrim0011-2024-biopharma-crohns-disease-current-treatment-current-treatment-physician-insights-crohns-disease-eu5
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
The court didn’t admit exclusive use of ‘the Hall of Fame’ | Clarivate
https://clarivate.com/intellectual-property/blog/exclusive-use-hall-of-fame
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-therapy-areas=bladder-cancer&wpv_paged=4&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-therapy-areas=diabetic-macular-edema&wpv_paged=2&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
COVID-19 | Clarivate
https://clarivate.com/life-sciences-healthcare/blog/tag/covid-19?clv_tag=covid-19
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Disease Landscape and Forecast Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/disease-landscape-and-forecast?clv-biopharma-geography=asia-pacific&wpv_paged=3&wpv_view_count=297543
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Biopharma Portfolio Strategy and Business Development
http://timbeckett-writing.com/index-358.html
timbeckett-writing.com
0 65
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
DOFOLLOW
Breast Implants and Reconstructive Devices | Market Insights | US | 2025 | Cl...
https://clarivate.com/life-sciences-healthcare/report/47042050-medtech-breast-implants-and-reconstructive-devices-market-insights-us-2025
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Schizophrenia - Special Topics - Special Topics: Novel Drugs in Psychiatry (U...
https://clarivate.com/life-sciences-healthcare/report/sptocg0016-2023-biopharma-schizophrenia-special-topics-special-topics-novel-drugs-in-psychiatry-us
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Market Access Insights | Clarivate
https://clarivate.com/life-sciences-healthcare/research-reports/market-access?clv-marketaccess-state=virginia&wpv_paged=3&wpv_view_count=297634
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Aortic Repair Devices | Market Insights | Asia Pacific (Supplemental) | 2025 ...
https://clarivate.com/life-sciences-healthcare/report/47042163-medtech-aortic-repair-devices-market-insights-asia-pacific-supplemental-2025
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Point of Care Digital Messaging | Clarivate
https://clarivate.com/life-sciences-healthcare/commercialization/point-of-care-digital-messaging
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Sjogren's Syndrome | Niche & Rare Disease Landscape & Forecast | US/EU5 | 202...
https://clarivate.com/life-sciences-healthcare/report/nrlfim0004-2020-biopharma-sjogrens-syndrome-niche-rare-disease-landscape-forecast-us-eu5-2020
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Gastroesophageal Cancer | Disease Landscape & Forecast | G7 | 2023 | Clarivate
https://clarivate.com/life-sciences-healthcare/report/dlsfon0015-2023-biopharma-gastroesophageal-cancer-disease-landscape-forecast-g7-2023
clarivate.com
80 1,174 541
DRG
https://authentication.decisionresourcesgroup.com/login/Solutions
NOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does authentication.decisionresourcesgroup.com have?
The backlinks page for authentication.decisionresourcesgroup.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on authentication.decisionresourcesgroup.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to authentication.decisionresourcesgroup.com dofollow or nofollow?
Backlinks to authentication.decisionresourcesgroup.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.